ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 45 filers reported holding ADICET BIO INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,941 | -45.6% | 10,906 | -3.6% | 0.00% | -100.0% |
| Q2 2023 | $27,488 | +161594.1% | 11,312 | +287.5% | 0.00% | 0.0% |
| Q1 2023 | $17 | +30.8% | 2,919 | +114.6% | 0.00% | 0.0% |
| Q4 2022 | $13 | -100.0% | 1,360 | -28.3% | 0.00% | – |
| Q3 2022 | $27,000 | +28.6% | 1,897 | +32.3% | 0.00% | – |
| Q2 2022 | $21,000 | -85.8% | 1,434 | -80.7% | 0.00% | -100.0% |
| Q1 2022 | $148,000 | +469.2% | 7,427 | +397.1% | 0.00% | – |
| Q4 2021 | $26,000 | +188.9% | 1,494 | +29.0% | 0.00% | – |
| Q3 2021 | $9,000 | -67.9% | 1,158 | -57.6% | 0.00% | -100.0% |
| Q2 2021 | $28,000 | -12.5% | 2,733 | +10.3% | 0.00% | 0.0% |
| Q1 2021 | $32,000 | +190.9% | 2,477 | +231.1% | 0.00% | – |
| Q4 2020 | $11,000 | -60.7% | 748 | -67.7% | 0.00% | – |
| Q3 2020 | $28,000 | – | 2,318 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 728,944 | $998,653 | 0.37% |
| DAFNA Capital Management LLC | 797,054 | $1,091,964 | 0.34% |
| COWEN AND COMPANY, LLC | 2,715,278 | $3,719,930 | 0.26% |
| Orbimed Advisors | 8,322,140 | $11,401,332 | 0.24% |
| TANG CAPITAL MANAGEMENT LLC | 1,226,352 | $1,680,102 | 0.24% |
| Carlyle Group Inc. | 2,115,385 | $2,876,924 | 0.12% |
| RTW INVESTMENTS, LP | 4,241,472 | $5,810,817 | 0.12% |
| Acuitas Investments, LLC | 136,779 | $187,387 | 0.11% |
| Decheng Capital Management III (Cayman), LLC | 200,201 | $274,275 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 142,168 | $195 | 0.02% |